Table 2 Deaths in the infliximab group

Age group(years)	Cause of death	No of infusions	Time since last infusion (months)	Other immunosuppression
40–59	Sudden death	1	0.5	MTX
40–59	Sudden death	10	6	AZA, certolizumab, adalimumab
20–39	Sudden death	4	66	AZA, MTX
40–59	Unknown	2	41	AZA
40–59	Cholangiocarcinoma	2	53	AZA, MTX
40–59	Secondary amyloidosis with multiple organ failure	5	29	AZA
40–59	Progressive multifocal leukoencephalopathy	4	24	AZA, natalizumab
40–59	Suicide	2	4	AZA
⩾60	Unknown following abdominal operation	10	2	AZA
⩾60	Aspergillus infection	20	0.5	AZA, MTX
40–59	Pancreatic cancer	16	1	AZA
20–39	Metastatic adenocarcinoma of unknown origin	21	20	AZA